24 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
regarding calculation formula and determination of individual remuneration for Directors ➢ Policies regarding Key Performance Indicators (KPI … under Performance-based Compensation, will be linked with the latest mid- to long-term key performance indicators (KPI) over a three-year period which
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
of individual remuneration for Directors Policies regarding Key Performance Indicators (KPI) for performance-based compensation (bonus and performance share … key performance indicators (KPI) over a three-year period which may include consolidated revenue, free cash flow, indicators on profit and R&D targets
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
23 Jun 23
Current report (foreign)
6:13am
Share Unit awards, which fall under Performance-based Compensation, will be linked with the latest mid- to long-term key performance indicators (KPI) over … a three-year period, which may include consolidated revenue, free cash flow, indicators on profit and R&D targets as transparent and objective KPI
6-K
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:20am
(“KPI”) used for the STI plan and for the LTI PSU awards. The KPIs included in the STI and LTI PSU awards were carefully evaluated by the Committee … before being approved by the Board. Each KPI has been set in order to align the short- and long-term strategies with shareholder returns, while also
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:11am
. Performance Share Unit awards, which fall under Performance-based Compensation, will be linked with the latest mid- to long-term key performance indicators (KPI … KPI. The variable range of payout rate for Performance Share Unit awards is from 0% to 200% (100% at target), based on performance achievement
6-K
kw1y cs3f
11 Jul 22
Current report (foreign)
6:05am
6-K
dfb7s
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
ol8xqn8t3jo91w9 7g
31 May 22
Current report (foreign)
6:07am
6-K
r2ux5ut5kh lev
1 Nov 21
Current report (foreign)
6:04am
6-K
p5d481eiu6aalkuw 5q
6 Aug 21
Current report (foreign)
6:10am
6-K
eymlhb
19 Jul 21
Current report (foreign)
6:02am
6-K
EX-99.1
yzna2mo t2c
21 Jun 21
Current report (foreign)
6:05am
6-K
EX-99.1
a70kbolquuv3vngn6
28 May 21
Current report (foreign)
6:07am
6-K
EX-99.1
rqks95o manadzp9n
28 May 21
Current report (foreign)
6:01am
6-K
EX-99.1
tz9stel uom
17 Dec 20
Current report (foreign)
6:01am
6-K
xrktgg0p
29 Jul 20
Current report (foreign)
6:07am
6-K
9nw5ge
27 May 20
Current report (foreign)
6:13am
6-K
EX-1
93yot9j 9gglbaakv7
27 May 20
Current report (foreign)
6:03am
6-K
EX-99.1
l784r
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
6-K
on6xydp
31 Jul 19
Current report (foreign)
6:42am